Overall, angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are the recommended treatments for NASH patients with hypertension [15]. The gene discussed is ACE; the disease is metabolic dysfunction-associated steatohepatitis.